Stock futures are little changed this morning. Investors are cautious ahead of a heavy slate of Q2 earnings and fresh developments in U.S. trade negotiations with Europe, India, and other partners.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
In commodities and fixed income, oil eased for the third straight session as fears of slower global growth due to trade tensions mounted. Gold also retreated from five-week highs on investor profit-taking, though it remains elevated amid tariff uncertainty. Market participants are awaiting a full week of earnings while policy watchers are also focused on how U.S.–EU and U.S.–India trade negotiations evolve before the August 1 tariff deadline.
In pre-market trading, S&P 500 futures rose 0.03%, Nasdaq futures fell 0.06% and Dow futures fell 0.09%
Check out this morning’s top movers from around Wall Street, compiled by The Fly, and subscribe to the Fly By on YouTube.
UP AFTER EARNINGS –
- Iqvia (IQV) up 8%
- D.R. Horton up 6%
- Tenet Healthcare (THC) up 5%
- Northrop Grumman (NOC) up 3%
- Quest Diagnostics (DGX) up 1%
- Paccar (PCAR) up 1%
- Valmont (VMI) up 1%
DOWN AFTER EARNINGS –
- Lockheed Martin (LMT) down 7%
- Philip Morris (PM) down 5%
- Sherwin-Williams (SHW) down 3%
- Danaher (DHR) down 2%
- General Motors (GM) down 2%
- Coca-Cola (KO) down 1%
- RTX (RTX) down 1%
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOC:
- Northrop Grumman reports Q2 net awards $7.4B, backlog totaled $89.7B
- Northrop Grumman raises FY25 free cash flow view to $3.05B-$3.35B
- Northrop Grumman raises FY25 adjusted EPS to $25.00-$25.40 from $24.95-$25.35
- Northrop Grumman reports Q2 EPS $8.15 with benefit, consensus $6.68
- Notable companies reporting before tomorrow’s open
